KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Eli Lilly (LLY) over the last 16 years, with Q3 2025 value amounting to $5.6 billion.

  • Eli Lilly's Net Income towards Common Stockholders rose 47533.75% to $5.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 billion, marking a year-over-year increase of 11997.99%. This contributed to the annual value of $10.6 billion for FY2024, which is 10208.38% up from last year.
  • Latest data reveals that Eli Lilly reported Net Income towards Common Stockholders of $5.6 billion as of Q3 2025, which was up 47533.75% from $5.7 billion recorded in Q2 2025.
  • Eli Lilly's Net Income towards Common Stockholders' 5-year high stood at $5.7 billion during Q2 2025, with a 5-year trough of -$57.4 million in Q3 2023.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was $1.8 billion (2023), whereas its average is $2.2 billion.
  • Per our database at Business Quant, Eli Lilly's Net Income towards Common Stockholders crashed by 10395.4% in 2023 and then skyrocketed by 179041.81% in 2024.
  • Quarter analysis of 5 years shows Eli Lilly's Net Income towards Common Stockholders stood at $1.7 billion in 2021, then increased by 12.26% to $1.9 billion in 2022, then grew by 13.01% to $2.2 billion in 2023, then surged by 101.39% to $4.4 billion in 2024, then rose by 26.59% to $5.6 billion in 2025.
  • Its Net Income towards Common Stockholders was $5.6 billion in Q3 2025, compared to $5.7 billion in Q2 2025 and $2.8 billion in Q1 2025.